Eugenol | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | |
Eugenol | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | |
Eugenol | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.82E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa01522 | Endocrine resistance | 2.16E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | |
Eugenol | hsa03013 | RNA transport | 3.98E-02 | 9 | P52298, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | |
Eugenol | hsa04010 | MAPK signaling pathway | 4.15E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa04014 | Ras signaling pathway | 3.65E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa04015 | Rap1 signaling pathway | 2.99E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa04066 | HIF-1 signaling pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa04068 | FoxO signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa04071 | Sphingolipid signaling pathway | 1.87E-02 | 6 | Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415 | EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2 | More | |
Eugenol | hsa04114 | Oocyte meiosis | 2.99E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa04140 | Autophagy - animal | 2.82E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa04146 | Peroxisome | 2.42E-02 | 5 | O43933, P56589, Q9UKG9, O75521, P33121 | PEX1, PEX3, CROT, ECI2, ACSL1 | More | |
Eugenol | hsa04150 | mTOR signaling pathway | 2.32E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa04152 | AMPK signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa04211 | Longevity regulating pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa04213 | Longevity regulating pathway - multiple species | 1.66E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa04510 | Focal adhesion | 3.48E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa04520 | Adherens junction | 8.29E-03 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 1.99E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | |
Eugenol | hsa04613 | Neutrophil extracellular trap formation | 7.32E-03 | 13 | O60603, P05164, P08246, Q9UM07, Q6FI13, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | |
Eugenol | hsa04640 | Hematopoietic cell lineage | 1.64E-03 | 2 | P04234, P20036 | CD3D, HLA-DPA1 | More | |
Eugenol | hsa04657 | IL-17 signaling pathway | 4.98E-02 | 6 | O00463, Q16539, P14780, Q9UJX4, P80188, P01375 | TRAF5, MAPK14, MMP9, ANAPC5, LCN2, TNF | More | |
Eugenol | hsa04658 | Th1 and Th2 cell differentiation | 1.85E-03 | 2 | P04234, P20036 | CD3D, HLA-DPA1 | More | |
Eugenol | hsa04659 | Th17 cell differentiation | 1.64E-03 | 2 | P20036, P04234 | HLA-DPA1, CD3D | More | |
Eugenol | hsa04672 | Intestinal immune network for IgA production | 3.16E-02 | 1 | P20036 | HLA-DPA1 | More | |
Eugenol | hsa04730 | Long-term depression | 1.16E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.93E-02 | 1 | Q9Y5S1 | TRPV2 | More | |
Eugenol | hsa04913 | Ovarian steroidogenesis | 1.16E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa04914 | Progesterone-mediated oocyte maturation | 2.16E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa04940 | Type I diabetes mellitus | 4.05E-02 | 1 | P20036 | HLA-DPA1 | More | |
Eugenol | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | |
Eugenol | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | |
Eugenol | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | |
Eugenol | hsa05142 | Chagas disease | 4.93E-02 | 1 | P04234 | CD3D | More | |
Eugenol | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | |
Eugenol | hsa05144 | Malaria | 3.09E-02 | 2 | P69905, P68871 | HBA2, HBB | More | |
Eugenol | hsa05166 | Human T-cell leukemia virus 1 infection | 9.87E-03 | 2 | P04234, P20036 | CD3D, HLA-DPA1 | More | |
Eugenol | hsa05169 | Epstein-Barr virus infection | 3.43E-03 | 2 | P20036, P04234 | HLA-DPA1, CD3D | More | |
Eugenol | hsa05202 | Transcriptional misregulation in cancer | 8.39E-04 | 13 | Q15532, P41732, P14780, P27930, P14923, Q16548, Q13077, O15550, P08069, P35226, P05164, P08246, P24522 | SS18, TSPAN7, MMP9, IL1R2, JUP, BCL2A1, TRAF1, UTX, IGF1R, BMI1, MPO, ELA2, GADD45A | More | |
Eugenol | hsa05205 | Proteoglycans in cancer | 3.48E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa05214 | Glioma | 9.95E-03 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa05215 | Prostate cancer | 1.33E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa05218 | Melanoma | 6.63E-03 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa05224 | Breast cancer | 1.49E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa05225 | Hepatocellular carcinoma | 1.33E-02 | 1 | P08069 | IGF1R | More | |
Eugenol | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.93E-02 | 1 | P04234 | CD3D | More | |
Eugenol | hsa05310 | Asthma | 2.71E-02 | 1 | P20036 | HLA-DPA1 | More | |
Eugenol | hsa05320 | Autoimmune thyroid disease | 3.60E-02 | 1 | P20036 | HLA-DPA1 | More | |
Eugenol | hsa05321 | Inflammatory bowel disease | 4.05E-02 | 1 | P20036 | HLA-DPA1 | More | |
Eugenol | hsa05330 | Allograft rejection | 3.60E-02 | 1 | P20036 | HLA-DPA1 | More | |
Eugenol | hsa05332 | Graft-versus-host disease | 4.05E-02 | 1 | P20036 | HLA-DPA1 | More | |
Eugenol | hsa05340 | Primary immunodeficiency | 1.81E-02 | 1 | P04234 | CD3D | More | |
Eugenol | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | |
Eugenol | hsa05416 | Viral myocarditis | 4.49E-02 | 1 | P20036 | HLA-DPA1 | More | |